The Company is seeking to raise approximately A$7.0 million in a Placement via the issue of
approximately 29.2 million new fully paid ordinary shares in the Company at A$0.24 per New Share.
• This raise is an equity placement as a bridge ahead of a proposed US listing.
• Directors and management reserve the right but not the obligation to subscribe for up to $500,000.
- Forums
- ASX - By Stock
- NVA
- Ann: Trading Halt
Ann: Trading Halt, page-23
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NVA (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.89M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 245 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 4655 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 94548 | 0.185 |
5 | 19410 | 0.180 |
3 | 36305 | 0.175 |
4 | 142216 | 0.170 |
3 | 125606 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 78844 | 2 |
0.200 | 23805 | 2 |
0.220 | 42000 | 2 |
0.225 | 43000 | 2 |
0.230 | 74646 | 3 |
Last trade - 09.44am 12/11/2024 (20 minute delay) ? |
Featured News
NVA (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online